Abstract:Neuropathology and Applied NeurobiologyVolume 36, Issue 4 p. 359-363 Genomic analysis of chromosome 22 in synchronous and histologically distinct intracranial tumours in a child U. Pohl, U. Pohl Departments of Histopathology,Search for more papers by this authorA. F. Dean, A. F. Dean Departments of Histopathology,Search for more papers by this authorK. Ichimura, K. Ichimura Division of Molecular Histopathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UKSearch for more papers by this authorL. Liu, L. Liu Division of Molecular Histopathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UKSearch for more papers by this authorJ. Nicholson, J. Nicholson Paediatric Oncology andSearch for more papers by this authorJ. Cross, J. Cross Radiology, andSearch for more papers by this authorV. P. Collins, V. P. Collins Departments of Histopathology, Division of Molecular Histopathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UKSearch for more papers by this author U. Pohl, U. Pohl Departments of Histopathology,Search for more papers by this authorA. F. Dean, A. F. Dean Departments of Histopathology,Search for more papers by this authorK. Ichimura, K. Ichimura Division of Molecular Histopathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UKSearch for more papers by this authorL. Liu, L. Liu Division of Molecular Histopathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UKSearch for more papers by this authorJ. Nicholson, J. Nicholson Paediatric Oncology andSearch for more papers by this authorJ. Cross, J. Cross Radiology, andSearch for more papers by this authorV. P. Collins, V. P. Collins Departments of Histopathology, Division of Molecular Histopathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UKSearch for more papers by this author First published: 13 May 2010 https://doi.org/10.1111/j.1365-2990.2010.01085.xCitations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Rickert CH, Paulus W. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst 2001; 17: 503–11 10.1007/s003810100496 CASPubMedWeb of Science®Google Scholar 2 Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC, Liang ML, Pan HC, Chung WY. Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer 2005; 104: 2156–67 10.1002/cncr.21430 CASPubMedWeb of Science®Google Scholar 3 Biegel JA. Molecular genetics of atypical teratoid / rhabdoid tumour. Neurosurg Focus 2006; 20: E11 10.3171/foc.2006.20.1.12 PubMedGoogle Scholar 4 Judkins AR, Eberhart CG, Wesseling P. Atypical teratoid/rhabdoid tumour. In WHO Classification of Tumours of the Central Nervous System 4th edn. Eds DN Louis, H Ohgaki, OD Wiestler, WK Cavenee. Lyon: IARC, 2007; 147–9 Google Scholar 5 Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of SMARCB1 in atypical teratoid and rhabdoid tumours. Cancer Res 1999; 59: 74–9 CASPubMedWeb of Science®Google Scholar 6 Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002; 8: 3461–7 CASPubMedWeb of Science®Google Scholar 7 Kingston RE, Bunker CA, Imbalzano AN. Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev 1996; 10: 905–20 10.1101/gad.10.8.905 CASPubMedWeb of Science®Google Scholar 8 Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, Wang X, Biegel JA, Pomeroy SL, Mesirov JP, Roberts CW. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci U S A 2005; 102: 17745–50 10.1073/pnas.0509014102 CASPubMedWeb of Science®Google Scholar 9 Janson K, Nedzi LA, David O, Schorin M, Walsh JW, Bhattacharjee M, Pridjian G, Tan L, Judkins AR, Biegel JA. Prediposition to atypical teratoid/rhabdoid tumour due to an inherited SMARCB1 mutation. Pediatr Blood Cancer 2006; 47: 279–84 10.1002/pbc.20622 PubMedWeb of Science®Google Scholar 10 Ammerlaan AC, Ararou A, Houben MP, Baas F, Tijssen CC, Teepen JL, Wesseling P, Hulsebos TJ. Long-term survival and transmission of SMARCB1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer 2008; 98: 474–9 10.1038/sj.bjc.6604156 CASPubMedWeb of Science®Google Scholar 11 Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 2007; 80: 805–10 10.1086/513207 CASPubMedWeb of Science®Google Scholar 12 Tufan K, Dogulu F, Kurt G, Emmez H, Ceviker N, Baykaner MK. Intracranial meningiomas of childhood and adolescence. Pediatr Neurosurg 2005; 41: 1–7 10.1159/000084858 PubMedWeb of Science®Google Scholar 13 Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld M, Collins VP, Dumanski JP, Rouleau GA. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994; 6: 180–4 10.1038/ng0294-180 CASPubMedWeb of Science®Google Scholar 14 Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, Von Deimling A. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995; 146: 827–32 CASPubMedWeb of Science®Google Scholar 15 Hansson CM, Buckley PG, Grigelioniene G, Piotrowski A, Hellström AR, Mantripragada K, Jarbo C, Mathiesen T, Dumanski JP. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. BMC Genomics 2007; 8: 16 10.1186/1471-2164-8-16 CASPubMedWeb of Science®Google Scholar 16 Biegel JA, Parmiter AH, Sutton LN, Rorke LB, Emanuel BS. Abnormalities of chromosome 22 in pediatric meningiomas. Genes Chromosomes Cancer 1994; 9: 81–7 10.1002/gcc.2870090202 CASPubMedWeb of Science®Google Scholar 17 Ragel BT, Jensen RL. Molecular genetics of meningiomas. Neurosurg Focus 2005; 19: E9 10.3171/foc.2005.19.5.10 PubMedGoogle Scholar 18 Wozniak K, Piaskowski S, Gresner SM, Golanska E, Bieniek E, Bigoszewska K, Sikorska B, Szybka M, Kulczycka-Wojdala D, Zakrzewska M, Zawlik I, Papierz W, Stawski R, Jaskolski DJ, Och W, Sieruta M, Liberski PP, Rieske P. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region. Cancer Genet Cytogenet 2008; 183: 14–20 10.1016/j.cancergencyto.2008.01.020 CASPubMedWeb of Science®Google Scholar 19 Schmitz U, Mueller W, Weber M, Sévenet N, Delattre O, Von Deimling A. INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer 2001; 84: 199–201 10.1054/bjoc.2000.1583 CASPubMedWeb of Science®Google Scholar 20 Seng TJ, Ichimura K, Liu L, Tingby O, Pearson DM, Collins VP. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosomes Cancer 2005; 43: 181–93 10.1002/gcc.20181 CASPubMedWeb of Science®Google Scholar 21 Ichimura K, Schmidt EE, Miyakawa A, Goike HM, Collins VP. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 1998; 22: 9–15 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1 CASPubMedWeb of Science®Google Scholar 22 Judkins AR. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Adv Anat Pathol 2007; 14: 335–9 10.1097/PAP.0b013e3180ca8b08 CASPubMedWeb of Science®Google Scholar Citing Literature Volume36, Issue4June 2010Pages 359-363 ReferencesRelatedInformation

Genomic Analysis of Chromosome 22 in Synchronous and Histologically Distinct Intracranial Tumours in a Child

Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor

OTHR-25 Germline Mutations in Pediatric Brain Tumor

Abstract 775: Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients

Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549–BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification

Abstract PR04: Novel somatic and germline mutations in intracranial germ cell tumors

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Abstract 2850: Noncoding regulatory mutations as driving event for the oncogenic core regulatory circuitries of neuroblastoma

Abstract 6372: Germline pathogenic variants are enriched in pediatric central nervous system tumor patients and associate with somatic functional consequences

Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature review

Abstract 4867: Identification of an Inv(16)-Encoded CBFA2T3-GLIS2 Fusion Protein in 34% of Non-Infant Acute Megkaryoblastic Leukemias: A Report from the Pediatric Cancer Genome Project

Clinical and Epidemiological Study of Intracranial Tumors in Children and Identification of Diagnostic Biomarkers for the Most Common Tumor Subtype and Their Relationship with the Immune Microenvironment Through Bioinformatics Analysis

Whole-Exome Sequencing Of Intracranial Germ Cell Tumors Reveals Frequent Mutations In Kit And Ras Pathways And Histone Demethylases

Abstract 2853: Comparison of methods for detection of hemispheric gliomas of infancy and their characteristic oncogenic tyrosine kinase gene fusions

Epco-32. Prospective Germline Sequencing Of Patients With Gliomas, Glioneuronal Or Neuronal Tumors

Primary Adult Sellar SMARCB1/INI1-deficient Tumor Represents a Subtype of Atypical Teratoid/rhabdoid Tumor

Molecular landscape of pediatric type IDH wildtype, H3 wildtype hemispheric glioblastomas

Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas.

Abstract 6155: Germline variants in cancer susceptibility genes and subsequent neoplasm risks after childhood cancer: A pooled analysis of two large-scale cohorts